Health ❯ Healthcare ❯ Patient Safety
Reporting Mechanisms Allergic Reactions Medication Errors Compounding Risks Medication Warnings Skin Reactions Serious Adverse Reactions Symptoms Medical Attention Hepatocellular Injury
The approval gives adults with blastic plasmacytoid dendritic cell neoplasm a second CD123‑targeted treatment backed by CADENZA response data, with a boxed warning for serious liver toxicity.